Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Lora Stanka Kirigin"'
Publikováno v:
Medicina, Vol 60, Iss 3, p 477 (2024)
Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. Howe
Externí odkaz:
https://doaj.org/article/fe58311769f84db3807955e81985d4d2
Autor:
Ljubica Vazdar, Ivo Darko Gabrić, Ivan Kruljac, Hrvoje Pintarić, Robert Šeparović, Lora Stanka Kirigin Biloš, Mirjana Pavlović, Ana Tečić Vuger, Mario Štefanović
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Trastuzumab has improved the prognosis of HER2 positive breast cancer, but cardiotoxicity remains a concern. We aimed to identify risk factors for trastuzumab-induced cardiotoxicity, with an emphasis on the HER2 Ile655Val single nucleotide p
Externí odkaz:
https://doaj.org/article/b0792d63096946bf96cbd11450c1c581
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 5, p 2663 (2022)
Cardiovascular complications are associated with advanced atherosclerosis. Although atherosclerosis is still regarded as an incurable disease, at least in its more advanced stages, the discovery of endothelial progenitor cells (EPCs), with their abil
Externí odkaz:
https://doaj.org/article/ccb89c0a7e9c47f9af103d4ce7afdfae
Autor:
Ivan Budimir, Sanja Stojsavljević, Davor Hrabar, Dominik Kralj, Alen Bišćanin, Lora Stanka Kirigin, Mario Zovak, Žarko Babić, Sven Bohnec, Ivan Budimir Jr
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 4., Pp 707-714 (2017)
The aim of this study was to demonstrate epidemiological, clinical and endoscopic characteristics of acute upper gastrointestinal bleeding (UGIB) with special reference to peptic ulcer bleeding (PUB). The study included 2198 consecutive patients refe
Externí odkaz:
https://doaj.org/article/e0f178b7ccdf444f85d671455cb5bd18
Ileal Herniation Through the Foramen of Winslow: Overeating as A Risk Factor for Internal Herniation
Autor:
Lora Stanka Kirigin, Marko Nikolić, Ivan Kruljac, Domagoj Marjan, Ivan Penavić, Neven Ljubičić, Ivan Budimir, Milan Vrkljan
Publikováno v:
Acta Clinica Croatica, Vol 55., Iss 1., Pp 167-171 (2016)
Internal hernias have an overall incidence of less than 1% and are difficult to diagnose clinically due to their nonspecific presentation. Most internal hernias present as strangulating closed-loop obstruction and delay in surgical intervention is re
Externí odkaz:
https://doaj.org/article/c3e06c2ae9b3488a925d5aa5355b37cf
Autor:
Ivan Kruljac, Lora Stanka Kirigin, Mateja Strinović, Jelena Marinković, Hrvoje Ivan Pećina, Vatroslav Čerina, Darko Stipić, Milan Vrkljan
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
Purpose. In low-income countries, prolactinomas are difficult to manage with dopamine agonists (DA). We compared the effectiveness of DA in microprolactinomas as a first line treatment and as adjuvant therapy for residual macroprolactinomas treated s
Externí odkaz:
https://doaj.org/article/db48be7df6d842a39b2fefaf8df35a6f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ljubica Vazdar, Ivan Darko Gabrić, Ivan Kruljac, Mario Štefanović, Robert Šeparović, Ana Tečić Vuger, Mirjana Pavlović, Hrvoje Pintarić, Lora Stanka Kirigin Biloš
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Trastuzumab has improved the prognosis of HER2 positive breast cancer, but cardiotoxicity remains a concern. We aimed to identify risk factors for trastuzumab-induced cardiotoxicity, with an emphasis on the HER2 Ile655Val single nucleotide polymorphi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::015493c57f2ca162666dd6372ddc8e57
https://pubmed.ncbi.nlm.nih.gov/34257352
https://pubmed.ncbi.nlm.nih.gov/34257352
Autor:
Lora Stanka Kirigin Biloš
Publikováno v:
Endocrine Oncology and Metabolism, Vol 3, Iss 2, Pp 49-55 (2017)
Despite the known maternal and infant benefits of breastfeeding, only about two-fifths of infants are exclusively breastfed for the first 6 months of life, with low milk supply among the most commonly cited reasons for breastfeeding cessation. Althou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::2264ef3f49148c915e6c170bf9a668eb